Login · Contact

Akorn Pharmaceuticals

 
Akorn Investor Relations
11.06.2014   Akorn Reports Preliminary 2014 Third Quarter Results
Read More
09.30.2014   Akorn Acquires Xopenex(R) (levalbuterol HCI) Inhalation Solution From Sunovion
Read More
08.12.2014   Akorn Completes Acquisition of VersaPharm
Read More
08.05.2014   Akorn Reports Preliminary 2014 Second Quarter Results
Read More
06.20.2014   Akorn Divests ECR Pharmaceuticals to Valeant
Read More
05.09.2014   Akorn to Acquire VersaPharm for $440 Million
Read More
05.06.2014   Akorn Reports 2014 First Quarter Results
Read More
04.17.2014   Akorn Completes Acquisition of Hi-Tech Pharmacal
Read More
04.14.2014   Akorn Receives FTC Clearance for Hi‐Tech Pharmacal Acquisition
Read More
04.10.2014   First Quarter 2014 Earnings Release and Conference Call Information
Read More
03.03.2014   Akorn, Inc. Announces Fourth Quarter 2013 Earnings Release and Conference Call Information
Read More
03.03.2014   2013 Q4 and Year-End Financial Results
Read More
11.20.2013   Akorn Acquires Three Branded Ophthalmic Products from Merck
Read More
11.05.2013   Akorn Reports Third Quarter 2013 Financial Results
Read More
10.14.2013   Akorn, Inc. Announces Third Quarter 2013 Earnings Release and Conference Call Information
Read More
08.27.2013   Akorn to Acquire Hi-Tech Pharmacal for $640 Million
Read More
08.15.2013   Akorn Reports Second Quarter 2013 Financial Results
Read More
07.11.2013   2nd Quarter 2013 Earnings Release & Conference Call
Read More
05.07.2013   Akorn Reports First Quarter 2013 Financial Results
Read More
04.03.2013   Akorn First Quarter 2013 Earnings Release Call
Read More
02.26.2013   Akorn Reports 2012 Fourth Quarter and Year-End Financial Results
Read More
02.05.2013   4th Quarter 2012 Earnings Release and Conference Call Information
Read More
01.14.2013   Akorn to Host a Conference Call to Discuss 2013 Financial Guidance
Read More
10.10.2012   Akorn, Inc. Announces Third Quarter 2012 Earnings Release and Conference Call Information
Read More
08.20.2012   Akorn to File Amended Unaudited Financial Statements for the Quarter Ended March 31, 2012
Read More
08.20.2012   Akorn Announces New Management Appointments
Read More
08.20.2012   Earnings Release 8-K (Q2 2012) Final (5)
Read More
07.06.2012   Second Quarter 2012 Earnings Release and Conference Call Information
Read More
05.08.2012   Akorn Reports Record First Quarter 2012 Financial Results
Read More
04.17.2012   Akorn, Inc. Announces First Quarter 2012 Earnings Release AND Conference Call Information
Read More
04.10.2012   Akorn Announces the Approval and Launch of Generic Vancocin®
Read More
03.06.2012   Akorn Reports 2011 Fourth Quarter and Year-End Financial Results
Read More
03.05.2012   Akorn Announces the Appointment of Dr. Adrienne Graves, Ph.D. to its Board of Directors
Read More
02.28.2012   Akorn Completes the Acquisition of Certain Assets of Kilitch Drugs in India
Read More
02.07.2012   Fourth Quarter 2011 Earnings Release and Conference Call Information
Read More
01.17.2012   Akorn Provides Financial Guidance for 2012
Read More
12.22.2011   Akorn Acquires Three Hospital-Based Branded Injectables from Lundbeck
Read More
11.01.2011   Akorn Reports Record Third Quarter 2011 Financial Results
Read More
10.07.2011   Akorn, Inc. Announces Third Quarter 2011 Earnings Release and Conference Call Information
Read More
10.06.2011   Akorn Enters Into an Agreement to Acquire Certain Assets of Kilitch Drugs in India
Read More
08.02.2011   Akorn Reports Second Quarter 2011 Financial Results
Read More
08.02.2011   Akorn to Acquire a Minority Stake in Aciex Therapeutics
Read More
06.23.2011   Akorn, Inc. Announces Second Quarter 2011 Earnings Release and Conference Call Information
Read More
06.02.2011   Akorn Announces Closing of $120 Million of Convertible Senior Notes Due 2016
Read More
05.26.2011   Akorn Announces Pricing of $100 Million of Convertible Senior Notes Due 2016
Read More
05.25.2011   Akorn Announces Proposed Offering of $100 Million of Convertible Senior Notes Due 2016
Read More
05.03.2011   Akorn Reports First Quarter 2011 Financial Results
Read More
05.03.2011   Akorn Enters Into an Agreement to Acquire Advanced Vision Research
Read More
04.07.2011   Akorn, Inc. Announces First Quarter 2011 Earnings Release and Conference Call Information
Read More
02.28.2011   Akorn Reports 2010 Fourth Quarter and Year-End Financial Results - Achieves Annual Core Revenue Growth of 81% -
Read More
01.30.2011   Akorn, Inc. Announces Fourth Quarter 2010 Earnings Release and Conference Call Information
Read More
12.28.2010   Akorn Announces the Sale of the Akorn-Strides Joint Venture Product Portfolio to Pfizer, Inc.
Read More
10.31.2010   Akorn Reports Third Quarter 2010 Results; Core Revenues Increase by 118%; Adjusted EBITDA of $6.3 million; Raises Outlook for 2010
Read More
10.06.2010   Akorn, Inc. Announces Third Quarter 2010 Earnings Release and Conference Call Information
Read More
09.15.2010   Akorn Announces Launch of Erythromycin Ophthalmic Ointment USP 1 g
Read More
08.02.2010   Akorn Reports Second Quarter 2010 Financial Results -Core Revenues Increase by 138%- -Adjusted EBITDA of $4.2 million; Raises Earnings Outlook for 2010-
Read More
08.01.2010   Akorn, Inc. Announces Second Quarter 2010 Earnings Release and Conference Call Information
Read More
05.02.2010   Akorn Reports First Quarter 2010 Financial Results -Achieves Positive Operating Income from Strong Demand in Core Business- -Raises Outlook for 2010-
Read More
04.20.2010   Akorn Announces FDA Approval to Re-Launch Erythromycin Ophthalmic Ointment USP 3.5 g
Read More
04.18.2010   Akorn, Inc. Announces First Quarter 2010 Earnings Release and Conference Call Information
Read More
04.14.2010   Akorn, Inc. Announces FDA Approval for Hydromorphone Hydrochloride Injection 10mg/mL in 1mL, 5mL and 50mL Doses
Read More
03.14.2010   Akorn Reports 2009 Fourth Quarter and Year-End Financial Results -Achieves Positive Fourth Quarter Cash Flow and Adjusted EBITDA- -Refocuses R&D efforts to Strengthen New Product Pipeline-
Read More
03.10.2010   Akorn, Inc. Enters into an Agreement to Sell Common Stock and Warrants
Read More
02.08.2010   Akorn Announces 4th Quarter 2009 Earnings Release and Call Information
Read More
02.08.2010   Akorn Fourth Quarter 2009 Earnings Release and Conference Call
Read More